Author name: DrugPatentWatch

Executive Summary The global pharmaceutical market presents two primary avenues for investors seeking to capitalize on the expiration of brand-name […]

The New Mandate: Understanding China’s IP Transformation For years, the narrative surrounding intellectual property in China has been one of

Introduction: Why Patent Intelligence is the Cornerstone of Market Access Strategy In the high-stakes arena of the global pharmaceutical industry,

In pharmaceuticals no event looms larger or casts a longer shadow than the patent cliff. It is a moment of

Litigation Summary and Analysis: Bayerische Motoren Werke Aktiengesellschaft v. Onesta IP, LLC (26-1338) Executive Summary Bayerische Motoren Werke Aktiengesellschaft (BMW)

The global rare disease treatment market, a sector born from legislative incentives to address profound unmet needs, is on an

Executive Summary: The Verdict on France’s Medical Revolution The global pharmaceutical landscape stands at the precipice of a new era,

1. The Economics of Time in Biopharma Biopharmaceutical asset valuation rests on a single, volatile variable: the duration of market

In the world of pharmaceuticals a patent represents the culmination of a decade or more of painstaking research, countless failed